A genome-wide CRISPR/Cas9 screen identifies calreticulin as a selective repressor of ATF6α

被引:1
|
作者
Tung, Joanne [1 ]
Huang, Lei [1 ]
George, Ginto [1 ]
Harding, Heather P. [1 ]
Ron, David [1 ]
Ordonez, Adriana [1 ]
机构
[1] Univ Cambridge, Cambridge Inst Med Res CIMR, Cambridge Biomed Campus, Cambridge, England
来源
ELIFE | 2024年 / 13卷
基金
英国惠康基金;
关键词
unfolded protein response; UPR; genome-wide CRISPR/Cas9 screen; ATF6; calreticulin; CRT; endoplasmic reticulum; CHO-K1; cells; Other; QUALITY-CONTROL PROTEINS; ENDOPLASMIC-RETICULUM; ER-STRESS; MESSENGER-RNA; NF-Y; ATF6; BINDING; ACTIVATION; CALNEXIN; ELEMENT;
D O I
10.7554/eLife.96979
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Activating transcription factor 6 (ATF6) is one of three endoplasmic reticulum (ER) transmembrane stress sensors that mediate the unfolded protein response (UPR). Despite its crucial role in long-term ER stress adaptation, regulation of ATF6 alpha (alpha) signalling remains poorly understood, possibly because its activation involves ER-to-Golgi and nuclear trafficking. Here, we generated an ATF6 alpha/Inositol-requiring kinase 1 (IRE1) dual UPR reporter CHO-K1 cell line and performed an unbiased genome-wide CRISPR/Cas9 mutagenesis screen to systematically profile genetic factors that specifically contribute to ATF6 alpha signalling in the presence and absence of ER stress. The screen identified both anticipated and new candidate genes that regulate ATF6 alpha activation. Among these, calreticulin (CRT), a key ER luminal chaperone, selectively repressed ATF6 alpha signalling: Cells lacking CRT constitutively activated a BiP::sfGFP ATF6 alpha-dependent reporter, had higher BiP levels and an increased rate of trafficking and processing of ATF6 alpha. Purified CRT interacted with the luminal domain of ATF6 alpha in vitro and the two proteins co-immunoprecipitated from cell lysates. CRT depletion exposed a negative feedback loop implicating ATF6 alpha in repressing IRE1 activity basally and overexpression of CRT reversed this repression. Our findings indicate that CRT, beyond its known role as a chaperone, also serves as an ER repressor of ATF6 alpha to selectively regulate one arm of the UPR.
引用
收藏
页数:31
相关论文
共 50 条
  • [1] A genome-wide CRISPR/Cas9 screen identifies octreotate radionuclide therapy
    Waldeck, Kelly
    Van Zuylekom, Jessica
    Cullinane, Carleen
    Gulati, Twishi
    Simpson, Kaylene J.
    Tothill, Richard W.
    Blyth, Benjamin
    Hicks, Rodney J.
    THERANOSTICS, 2023, 13 (14): : 4745 - 4761
  • [2] Genome-wide CRISPR/Cas9 screen identifies regulators of BCMA expression on multiple myeloma cells
    Ajore, Ram
    Mattsson, Jenny
    Pertesi, Maroulio
    Ekdahl, Ludvig
    Ali, Zain
    Hansson, Markus
    Nilsson, Bjoern
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [3] Genome-wide CRISPR/Cas9 screen identifies regulators of BCMA expression on multiple myeloma cells
    Ram Ajore
    Jenny Mattsson
    Maroulio Pertesi
    Ludvig Ekdahl
    Zain Ali
    Markus Hansson
    Björn Nilsson
    Blood Cancer Journal, 14
  • [4] Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication
    Han, Julianna
    Perez, Jasmine T.
    Chen, Cindy
    Li, Yan
    Benitez, Asiel
    Kandasamy, Matheswaran
    Lee, Yoontae
    Andrade, Jorge
    tenoever, Benjamin
    Manicassamy, Balaji
    CELL REPORTS, 2018, 23 (02): : 596 - 607
  • [5] A genome-wide CRISPR/Cas9 screen identifies novel regulators of GSDMD pore formation in engineered macrophages
    Evavold, Charles Lee
    Hafner-Bratkovic, Iva
    Jerala, Roman
    Kagan, Jonathan C.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [6] Genome-Wide CRISPR/Cas9 Screen Towards Identification of the Lacritin Homeostasis Receptor
    Teixeira, Karina Luiza Dias
    Doench, John
    Laurie, Gordon W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [7] A Genome-Wide CRISPR/Cas9 Screen Identifies Druggable Targets that Synergize with TKIs for Potential Combination Treatment of Leukemia
    Herrera, Maria
    Andersen, Aram
    Piechaczyk, Laure
    Floisand, Yngvar
    Enserink, Jorrit
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S183 - S183
  • [8] A Crispr/Cas9 Drop-out Screen Identifies Genome-Wide Genetic Valnerubilities in Acute Myeloid Leukaemia
    Tzelepis, Konstantinos
    Koike-Yusa, Hiroko
    De Braekeleer, Etienne
    Li, Yilong
    Metzakopian, Emmanouil
    Dovey, Oliver M.
    Mupo, Annalisa
    Grinkevich, Vera
    Mazan, Milena M.
    Gozdecka, Malgorzata
    Cooper, Jonathan L.
    Patel, Miten
    McKerrell, Thomas David Hardman
    Chen, Bin
    Ponstingl, Hannes
    Huntly, Brian J. P.
    McDermott, Ultan
    Saez-Rodriguez, Julio
    Iorio, Francesco
    Yusa, Kosuke
    Vassiliou, George S.
    BLOOD, 2015, 126 (23)
  • [9] A Genome-Wide CRISPR/Cas9 Screen Identifies a Role for Early Endosomes in Hepatitis E Virus RNA Replication
    Oechslin, Noemie
    Da Silva, Nathalie
    Ankavay, Maliki
    Pollan, Angela
    Moradpour, Darius
    Gouttenoire, Jerome
    SWISS MEDICAL WEEKLY, 2022, 152 : 8S - 8S
  • [10] A Genome-Wide CRISPR/Cas9 Screen Identifies an Essential Role of SLC35A1 in rAAV Transduction
    Zhang, Xiujuan
    Ning, Kang
    Hao, Siyuan
    Feng, Zehua
    Kuz, Cagla Aksu
    McFarlin, Shane
    Richart, Donovan G.
    Cheng, Fang
    Yan, Ziying
    Qiu, Jianming
    MOLECULAR THERAPY, 2024, 32 (04) : 37 - 37